538 results
Page 13 of 27
6-K
EX-99.1
m00y6
1 Aug 13
Teva Reports Second Quarter 2013 Results
12:00am
6-K
EX-99.1
wsl5 nh40x11n49
29 Jul 13
English Court of Appeal finds in favor of Teva on Copaxone® patent litigation and upholds validity of Copaxone patent until May 2015
12:00am
6-K
EX-99.1
ce3w6e
29 Jul 13
Live Filing
12:00am
6-K
EX-99.1
6xpl4 1dxpu
26 Jul 13
Teva Provides Update on COPAXONE® Litigation
12:00am
6-K
EX-99.1
osm 7rpfpz4
25 Jul 13
Teva and Lonza Announce Mutual Decision to Discontinue Biologics Joint Venture
12:00am
6-K
EX-99.1
vopi1mcb
23 Jul 13
Live Filing
12:00am
6-K
bk7ipa
18 Jul 13
Current report (foreign)
12:00am
6-K
EX-99.1
kd92lijaa329ywp9jupx
1 Jul 13
Live Filing
12:00am
6-K
EX-99.1
jzmsn vt6lap
24 Jun 13
Teva launches generic version of Viagra® (sildenafil) in countries across Europe
12:00am
6-K
EX-99.1
ad1abao7rq 7p47
17 Jun 13
Teva Strengthens Respiratory Franchise with Acquisition of Microdose Therapeutx
12:00am
6-K
EX-99.1
szrzro
12 Jun 13
Teva Reaches Settlement Agreement with Pfizer and Nycomed Regarding Generic Protonix® (Pantoprazole) Tablets
12:00am
6-K
EX-32.1
ntkb c12kdt
12 Jun 13
Live Filing
12:00am
6-K
EX-99.1
prljy0y 7vqau1yb
3 Jun 13
Live Filing
12:00am
6-K
EX-99
bdwe06 gkphpcem
30 May 13
TEVA ANNOUNCES FDA ACCEPTANCE OF sNDA FOR A HIGHER CONCENTRATION DOSE OF COPAXONE®GIVEN THREE TIMES A WEEK
12:00am
6-K
EX-99.1
3kdpc
8 May 13
Adasuve® (loxapine) inhalation powder is approved in the U.S. for the acute treatment of agitation associated with schizophrenia and bipolar disorder
12:00am
6-K
EX-32.1
hrwne5wa4ge1qr2hd
6 May 13
Live Filing
12:00am
6-K
EX-99.1
509opxmyhf92iswdgk
2 May 13
Teva Reports First Quarter 2013 Results
12:00am
6-K
gfeo1744r
2 May 13
Current report (foreign)
12:00am
6-K
EX-99.1
bn4smb2dcnjzd9 4z
1 May 13
FDA Approves Over-The-Counter Availability of Plan B One-Step® (levonorgestrel) tablet 1.5 mg for Consumers 15 and Over
12:00am
6-K
EX-99.1
z6h lcwex
29 Apr 13
Live Filing
12:00am